We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-14.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$68.5B
AUM Growth
-$9.16B
(-12%)
Cap. Flow
+$4.06B
Cap. Flow
% of AUM
5.93%
Top 10 Holdings %
Top 10 Hldgs %
21.45%
Holding
3,375
New
359
Increased
2,433
Reduced
285
Closed
282
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$124M |
| 2 |
Apple
AAPL
|
+$110M |
| 3 |
Microsoft
MSFT
|
+$104M |
| 4 |
Amazon
AMZN
|
+$71.3M |
| 5 |
Warner Bros
WBD
|
+$69.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$61.6M |
| 2 |
CERN
Cerner Corp
CERN
|
+$50.9M |
| 3 |
NXP Semiconductors
NXPI
|
+$31.4M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$30.4M |
| 5 |
Yum China
YUMC
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.13% |
| 2 | Healthcare | 14.42% |
| 3 | Financials | 13.45% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Abercrombie & Fitch
ANF
$4.95B
| $2.5M | ﹤0.01% |
147,536
-9,625
| -6% | -$266K |
|
|
SAGE
1652
DELISTED
Sage Therapeutics
SAGE
| $2.49M | ﹤0.01% |
77,189
+34,865
| +82% | +$1.17M |
|
|
RC
1653
Ready Capital
RC
$303M
| $2.49M | ﹤0.01% |
208,760
+26,482
| +15% | +$373K |
|
1654
Marcus & Millichap
MMI
$1.19B
| $2.49M | ﹤0.01% |
67,221
+63
| +0.1% | +$2.74K |
|
1655
CarGurus
CARG
$3.43B
| $2.49M | ﹤0.01% |
115,676
+17,732
| +18% | +$525K |
|
1656
Buckle
BKE
$2.35B
| $2.48M | ﹤0.01% |
89,581
+5,123
| +6% | +$161K |
|
1657
Scansource
SCSC
$1.13B
| $2.47M | ﹤0.01% |
79,457
+2,020
| +3% | +$70.8K |
|
|
CDMO
1658
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.47M | ﹤0.01% |
162,072
+44,636
| +38% | +$660K |
|
1659
Arvinas
ARVN
$571M
| $2.46M | ﹤0.01% |
58,563
+9,239
| +19% | +$464K |
|
1660
Delek US
DK
$3.61B
| $2.46M | ﹤0.01% |
95,326
-2,930
| -3% | -$79.1K |
|
|
TGI
1661
DELISTED
Triumph Group
TGI
| $2.46M | ﹤0.01% |
185,149
+9,987
| +6% | +$189K |
|
1662
AtriCure
ATRC
$2.07B
| $2.45M | ﹤0.01% |
59,955
+8,529
| +17% | +$404K |
|
1663
PC Connection
CNXN
$2.14B
| $2.45M | ﹤0.01% |
55,604
+1,301
| +2% | +$61.7K |
|
1664
PetMed Express
PETS
$42.3M
| $2.45M | ﹤0.01% |
122,894
+305
| +0.2% | +$6.82K |
|
|
INN
1665
Summit Hotel Properties
INN
$698M
| $2.44M | ﹤0.01% |
336,234
+9,854
| +3% | +$86.7K |
|
1666
Peloton Interactive
PTON
$2.42B
| $2.44M | ﹤0.01% |
266,120
+2,346
| +0.9% | +$37.6K |
|
1667
Iovance Biotherapeutics
IOVA
$2.74B
| $2.44M | ﹤0.01% |
220,944
+97,707
| +79% | +$1.28M |
|
1668
Agilysys
AGYS
$3.04B
| $2.44M | ﹤0.01% |
51,583
+89
| +0.2% | +$3.47K |
|
1669
Benchmark Electronics
BHE
$2.95B
| $2.43M | ﹤0.01% |
107,746
+2,784
| +3% | +$67.2K |
|
1670
Digi International
DGII
$3.04B
| $2.42M | ﹤0.01% |
100,004
+2,369
| +2% | +$51.3K |
|
1671
Perdoceo Education
PRDO
$2.13B
| $2.42M | ﹤0.01% |
205,587
+1,933
| +0.9% | +$21.2K |
|
1672
Sonic Automotive
SAH
$2.6B
| $2.42M | ﹤0.01% |
65,918
-8,440
| -11% | -$362K |
|
1673
Apogee Enterprises
APOG
$913M
| $2.41M | ﹤0.01% |
61,413
-9,576
| -13% | -$410K |
|
1674
Regenxbio
RGNX
$705M
| $2.4M | ﹤0.01% |
97,355
+9,928
| +11% | +$248K |
|
|
EFC
1675
Ellington Financial
EFC
$1.71B
| $2.4M | ﹤0.01% |
163,839
+14,394
| +10% | +$226K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, RhumbLine Advisers held 3,375 positions worth $68.5B, down 12% from $77.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers deployed $4.06B of net new capital in Q2 2022, opening 359 new positions and adding to 2,433 existing holdings. Its largest new stake was Aspen Technology Inc: 81,883 shares worth $15M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AT&T, an estimated $61.6M trimmed.
- RhumbLine Advisers's largest Q2 2022 buy was Aspen Technology Inc: 81,883 shares worth $15M.
- RhumbLine Advisers added most to Linde in Q2 2022, an estimated $124M increase.
- RhumbLine Advisers's biggest Q2 2022 reduction was AT&T, cutting an estimated $61.6M.
- RhumbLine Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $50.9M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $68.5B portfolio in Q2 2022.
- RhumbLine Advisers opened 359 new positions and closed 282 in Q2 2022.
- RhumbLine Advisers's portfolio value fell 12% quarter-over-quarter to $68.5B.
Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.